Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy.
Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T. Shibuya H, et al. Among authors: imaoka h. Cancer Chemother Pharmacol. 2018 Oct;82(4):661-668. doi: 10.1007/s00280-018-3656-y. Epub 2018 Jul 27. Cancer Chemother Pharmacol. 2018. PMID: 30054710
Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors.
Imaoka H, Sasaki M, Takahashi H, Hashimoto Y, Ohno I, Mitsunaga S, Watanabe K, Umemoto K, Kimura G, Suzuki Y, Kan M, Ikeda M. Imaoka H, et al. Oncologist. 2019 Jan;24(1):47-53. doi: 10.1634/theoncologist.2017-0651. Epub 2018 Aug 2. Oncologist. 2019. PMID: 30072388 Free PMC article. Clinical Trial.
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy.
Suzuki Y, Kan M, Kimura G, Umemoto K, Watanabe K, Sasaki M, Takahashi H, Hashimoto Y, Imaoka H, Ohno I, Mitsunaga S, Ikeda M. Suzuki Y, et al. Among authors: imaoka h. J Gastroenterol. 2019 Mar;54(3):281-290. doi: 10.1007/s00535-018-1518-3. Epub 2018 Oct 8. J Gastroenterol. 2019. PMID: 30298469 Free PMC article. Clinical Trial.
Endoscopic Ultrasound-Guided Gallbladder Drainage for Aberrant Right Posterior Duct Obstruction Developing after Placement of a Covered Self-Expandable Metallic Stent in a Patient with Distal Biliary Obstruction.
Suzuki Y, Hashimoto Y, Shibuki T, Kan M, Kimura G, Umemoto K, Watanabe K, Sasaki M, Takahashi H, Imaoka H, Ohno I, Mitsunaga S, Ikeda M. Suzuki Y, et al. Among authors: imaoka h. Case Rep Gastroenterol. 2018 Nov 28;12(3):722-728. doi: 10.1159/000492215. eCollection 2018 Sep-Dec. Case Rep Gastroenterol. 2018. PMID: 30631259 Free PMC article.
Impact of the Duration of Diabetes Mellitus on the Outcome of Metastatic Pancreatic Cancer Treated with Gemcitabine: A Retrospective Study.
Iizumi S, Kuchiba A, Okusaka T, Ikeda M, Sakamoto Y, Kondo S, Morizane C, Ueno H, Osame K, Mitsunaga S, Ohno I, Imaoka H, Hashimoto Y, Takahashi H, Sasaki M, Ohashi K. Iizumi S, et al. Among authors: imaoka h. Intern Med. 2019 Sep 1;58(17):2435-2441. doi: 10.2169/internalmedicine.2539-18. Epub 2019 Jun 7. Intern Med. 2019. PMID: 31178491 Free PMC article.
A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic Cancer.
Kobayashi S, Ueno M, Ikeda M, Ozaka M, Sano Y, Hirotani A, Tozuka Y, Fukushima T, Tezuka S, Moriya S, Umemoto K, Watanabe K, Sasaki M, Hashimoto Y, Imaoka H, Ohno I, Mitsunaga S, Yamada I, Sasaki T, Sasahira N, Morimoto M. Kobayashi S, et al. Among authors: imaoka h. Pancreas. 2020 Feb;49(2):187-192. doi: 10.1097/MPA.0000000000001484. Pancreas. 2020. PMID: 32011536
203 results